Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 3Phase NA 2Phase 2 2Phase 2/3 1

Status

Completed 6Unknown 2Terminated 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Carcinoma, Non-Small-Cell Lung 387Breast Neoplasms 368Colorectal Neoplasms 242Stomach Neoplasms 221Carcinoma, Hepatocellular 155Lung Neoplasms 125Neoplasms 122Pancreatic Neoplasms 112Prostatic Neoplasms 101Rectal Neoplasms 98Neoplasm Metastasis 98Recurrence 94Ovarian Neoplasms 92Nasopharyngeal Carcinoma 89Esophageal Neoplasms 84Esophageal Squamous Cell Carcinoma 83Lymphoma, Large B-Cell, Diffuse 80Melanoma 78Lymphoma 72Small Cell Lung Carcinoma 71Sarcoma 71Leukemia, Myeloid, Acute 71Uterine Cervical Neoplasms 70Brain Neoplasms 70Squamous Cell Carcinoma of Head and Neck 67Multiple Myeloma 67Head and Neck Neoplasms 67Carcinoma, Renal Cell 65Triple Negative Breast Neoplasms 63Colonic Neoplasms 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Febrile Neutropenia × Clear all
NCT02544685 2019-01-17

FENSY

S&D Pharma SK s.r.o.

Phase 2 Unknown
120 enrolled
Classical hematology

Neoplasms, Neutropenia, Febrile Neutropenia

NCT03449693 2018-03-05

Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia

Universidad Nacional Autonoma de Mexico

Phase 2 Unknown
214 enrolled
Classical hematology

Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡